Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets

Por Furst, Daniel E., Emery, Paul
Publicado em 2014

Targeting inflammatory pathways in axial spondyloarthritis

Por Furst, Daniel E., Louie, James S.
Publicado no Arthritis Res Ther (2019)

Safety and feasibility of umbilical cord mesenchymal stem cells in treatment-refractory systemic lupus erythematosus nephritis: time for a double-blind placebo-controlled trial to...

Por Woodworth, Thasia G, Furst, Daniel E
Publicado no Arthritis Res Ther (2014)

Timely renal transplantation for scleroderma end-stage kidney disease patients can improve outcomes and quality of life

Por Woodworth, Thasia G., Furst, Daniel E.
Publicado no Ann Transl Med (2019)

Description of the Efficacy and Safety of Three New Biologics in the Treatment of Rheumatoid Arthritis

Por Storage, Steven S., Agrawal, Harsh, Furst, Daniel E.
Publicado em 2010

Salicylate Metabolism in Twins: EVIDENCE SUGGESTING A GENETIC INFLUENCE AND INDUCTION OF SALICYLURATE FORMATION

Por Furst, Daniel E., Gupta, Niroo, Paulus, Harold E.
Publicado em 1977

The impact of tocilizumab on physical function and quality of life in patients with rheumatoid arthritis: a systematic literature review and interpretation

Por Townes, Shatara V, Furst, Daniel E, Thenkondar, Anuradha
Publicado no Open Access Rheumatol (2012)

Biosimilars and the extrapolation of indications for inflammatory conditions

Por Tesser, John RP, Furst, Daniel E, Jacobs, Ira
Publicado no Biologics (2017)

Points to consider for clinical trials of the gastrointestinal tract in systemic sclerosis

Por Furst, Daniel E., Braun-Moscovic, Yolanda, Khanna, Dinesh
Publicado no Rheumatology (Oxford) (2017)

Functional disability and other health-related quality-of-life domains: points to consider for clinical trials in systemic sclerosis

Por Khanna, Dinesh, Hays, Ron D., Furst, Daniel E.
Publicado no Rheumatology (Oxford) (2017)

Points to consider for designing trials in systemic sclerosis patients with arthritic involvement

Por Clements, Philip, Allanore, Yannick, Furst, Daniel E., Khanna, Dinesh
Publicado no Rheumatology (Oxford) (2017)

Review: Hematopoietic Stem Cell Transplantation for Scleroderma: Effective Immunomodulatory Therapy for Patients With Pulmonary Involvement

Por Sullivan, Keith M., Shah, Ankoor, Sarantopoulos, Stefanie, Furst, Daniel E.
Publicado no Arthritis Rheumatol (2016)

Clinical trials in systemic sclerosis: lessons learned and outcomes

Por Matucci-Cerinic, Marco, Steen, Virginia D, Furst, Daniel E, Seibold, James R
Publicado em 2007

Review of Routine Laboratory Monitoring for Patients with Rheumatoid Arthritis Receiving Biologic or Nonbiologic DMARDs

Por Rigby, William F. C., Lampl, Kathy, Low, Jason M., Furst, Daniel E.
Publicado no Int J Rheumatol (2017)

Points to consider—Raynaud’s phenomenon in systemic sclerosis

Por Cutolo, Maurizio, Smith, Vanessa, Furst, Daniel E., Khanna, Dinesh, Herrick, Ariane L.
Publicado no Rheumatology (Oxford) (2017)

Pulmonary hypertension related to systemic sclerosis: points to consider for clinical trials

Por Humbert, Marc, Singh, Manjit, Furst, Daniel E., Khanna, Dinesh, Seibold, James R.
Publicado no Rheumatology (Oxford) (2017)

An International, Web-Based, Prospective Cohort Study to Determine Whether the Use of ACE Inhibitors prior to the Onset of Scleroderma Renal Crisis Is Associated with Worse Outcome...

Por Hudson, Marie, Baron, Murray, Lo, Ernest, Weinfeld, Joanna, Furst, Daniel E., Khanna, Dinesh
Publicado em 2010

Work Productivity in Scleroderma – Analysis from the UCLA Scleroderma Quality of Life Study

Por Singh, Manjit K., Clements, Philip J., Furst, Daniel E., Maranian, Paul, Khanna, Dinesh
Publicado em 2012

Longer durations of antitumour necrosis factor treatment are associated with reduced risk of cardiovascular events in patients with rheumatoid arthritis

Por Nurmohamed, Michael, Bao, Yanjun, Signorovitch, James, Trahey, Alex, Mulani, Parvez, Furst, Daniel E
Publicado no RMD Open (2015)

Systemic Sclerosis Trial Design Moving Forward

Por Johnson, Sindhu R., Khanna, Dinesh, Allanore, Yannick, Matucci-Cerinic, Marco, Furst, Daniel E.
Publicado no J Scleroderma Relat Disord (2018)